
Astorg beats sponsors to acquire CordenPharma
Private equity firm Astorg has acquired German CDMO CordenPharma from International Chemical Investors Group (ICIG).
The GP competed alongside Advent International in the final round of an auction led by William Blair, as reported by Unquote's sister publication Mergermarket.
The company's founders will reinvest under the transaction, Astorg said.
ICIG has been preparing CordenPharma for a sale since at least August 2021 after its EBITDA projections rocketed thanks to its lipid technology that backs the Moderna vaccine, as reported.
Astorg said the target had experienced strong organic growth thanks to its position in complex and fast-growing drug modalities including mRNA vaccines, peptides and high-potency compounds for oncology therapeutics.
Pre-pandemic the company had EUR 60m-70m EBITDA but that has since ballooned to between EUR 260m-300m, as reported.
The deal was signed at around EUR 2.5bn, according to media reports, with the vendor seeking a minimum valuation of EUR 2bn, as reported.
ICIG intends to focus on its chemicals portfolio going forward, it said in a statement.
Last year, Astorg filed its eighth flagship fund in Luxembourg, which will invest in companies with an enterprise value greater than EUR 600m, according to document's on Astorg's website.
That fund's predecessor, Astorg VII, held a final close in January 2019 at EUR 4bn.
The GP also recently closed its inaurgural mid-cap fund on its EUR 1.3bn hard cap.
Advisors
ICIG - William Blair (M&A); Freshfields (legal); PwC (financial, tax); ERM (EHS); and LEK (commercial).
Astorg - Jefferies International (lead M&A) and Houlihan Lokey (M&A); Latham & Watkins (legal), EY (financial, tax); Alvarez & Marsal (operations) and BCG (commercial).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds